| (Values in U.S. Thousands) | Dec, 2021 | Dec, 2020 | Dec, 2019 | Dec, 2018 | Dec, 2017 |
| Sales | 0 | 5,800 | 19,810 | 23,340 | 21,270 |
| Sales Growth | -100.00% | -70.72% | -15.12% | +9.73% | -4.66% |
| Net Income | -122,310 | -4,420 | -2,050 | -260 | -1,080 |
| Net Income Growth | -2,667.19% | -115.61% | -688.46% | +75.93% | +63.01% |
Blackrock Technology and Private Equity Term Tru (BTX)
Blackrock Technology and Private Equity Term Tru (BTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Brooklyn ImmunoTherapeutics LLC. is a late clinical-stage biopharmaceutical company. It is focused on IL-2 cytokine-based therapies in treating patients with cancer. Brooklyn ImmunoTherapeutics LLC., formerly known as NTN Buzztime, is based in CARLSBAD, Calif.